Glomerular Basement Membrane Antibody, IgG
Glomerular basement membrane (GBM) antibodies are auto-antibodies developed against thin membranes in the body such as glomerular basement membrane in the kidney and subendothelial membranes in the lungs. Production of this autoimmune antibody often causes damage to these membranes, which then results in organ damage such as in kidneys, and in some cases the lung. The glomerular basement membrane is a thin layer of collagen in the glomerulus of the kidney; it filters the waste and metabolic byproducts from the blood. The alveolar basement membranes are also thin membranes found in the lungs; it serves as a membrane between inspired air and blood. GBM antibody is an autoimmune antibody (mostly IgG) produced against GBM, which serves as antigens.
Production of this antibody leads to renal disease, including glomerulonephritis, renal hemorrhage, and renal failure. Symptoms associated with renal involvement are water retention or edema, hypertension, and low urine output. Sometimes the GBM antibodies cross-react with the alveolar basement membrane (ABM) in the lungs and cause respiratory distress and pulmonary hemorrhage. If there is both renal and pulmonary involvement, the disorder is called Goodpasture's Syndrome. Other diseases such as antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis can cause similar damage and symptoms making the Anti-GBM antibody testing vital in diagnosing Goodpasture's syndrome. The disease is found primarily in men ages 20 to 40, but is also seen in men and women older than 50. Renal disease without pulmonary involvement is typically seen in older patients and mostly in women.
- As an aid in diagnosis of renal failure and/or pulmonary hemorrhage
- Aids diagnosis of Goodpasture’s syndrome
- Differentiates Goodpasture’s syndrome from other autoimmune disorders
- Differential diagnosis of autoimmune glomerulonephritis
Present in (Positive):
- Goodpasture’s syndrome
- Anti-GBM glomerulonephritis
| Result | EU/mL |
| Negative | ≤5 |
| Borderline | 5.1–20.0 |
| Positive | ≥20.0 |
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Medicine (Baltimore). 2011 Sep;90(5):303-11. [PMID: 21862934]
- Ann Clin Biochem. 2007 Sep;44(Pt 5):432-42. [PMID: 17761028]
- Nephrol Dial Transplant. 2006 Feb;21(2):397-401. [PMID: 16234289]
- Nephrol Dial Transplant. 1997 Apr;12(4):646-8. [PMID: 9140985]
- Kidney Int. 1973 Feb;3(2):74-89. [PMID: 4571918]